بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

tolmar therapeutics inc. - acetato de leuprolida - acetato de leuprolida....45 mg / 85:15 poli(dl-lactido-co-glicolido)....217 mg / n-metil-2 -pirrolidona....217 mg

بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

tolmar, inc. - leuprolida acetato - leuprolida acetato....22,50 mg

بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

tolmar therapeutics inc. - leuprolida acetato - leuprolida acetato....22,5 mg

بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

tolmar therapeutics inc. - leuprolida acetato - leuprolida acetato....45 mg

كندا - الإنجليزية - Health Canada

tolmar international ltd. - leuprolide acetate - powder for suspension, sustained-release - 7.5mg - leuprolide acetate 7.5mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

tolmar international ltd. - leuprolide acetate - powder for suspension, sustained-release - 22.5mg - leuprolide acetate 22.5mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

tolmar international ltd. - leuprolide acetate - powder for suspension, sustained-release - 30mg - leuprolide acetate 30mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

tolmar international ltd. - leuprolide acetate - powder for suspension, sustained-release - 45mg - leuprolide acetate 45mg - antineoplastic agents

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

tolmar inc. - leuprolide acetate (unii: 37jns02e7v) (leuprolide - unii:efy6w0m8tg) - leuprolide acetate 7.5 mg in 0.25 ml - eligard® is indicated for the palliative treatment of advanced prostate cancer. hypersensitivity eligard® is contraindicated in patients with hypersensitivity to gnrh, gnrh agonist analogs or any of the components of eligard® .  anaphylactic reactions to synthetic gnrh or gnrh agonist analogs have been reported in the literature. risk summary based on findings in animal studies and mechanism of action, eligard® may cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)] . there are no available data in pregnant women to inform the drug-associated risk. expected hormonal changes that occur with eligard® treatment increase the risk for pregnancy loss. in animal developmental and reproductive studies, major fetal abnormalities were observed after administration of leuprolide acetate throughout gestation in rats. advise pregnant patients and females of reproductive potential of the potential risk to the fetus (see data) . animal data in animal developmental and reproduc

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

tolmar inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 50 mg in 500 mg